Hold at $80.39 200 SMA defense with Q3 binary catalyst-bounded patience; staged adds on reclaim, 55-65% trim on failure
Hold at the 200 SMA defense level ($80.39) with Q3 mid-October as binary catalyst checkpoint. Valuation floor (5.2x forward P/E, 0.28 PEG, $22B FCF, $24.7B liquid resources, $8B annual buyback) prevents Underweight. Broken short-term momentum stack (below 10 EMA, 50 SMA at $85.36, MACD negative, RSI at 41, $1.08 cushion to 200 SMA) prevents Overweight. Pre-committed scenarios convert passive wait into structured reassessment: reclaim converts to staged 1/3 adds; failure converts to 55-65% Underweight trim. Hard stop at $74.00 weekly close. Patience with pre-committed triggers, not conviction in either direction.
| Position | Action |
|---|---|
| Relief rally to $83-85 (50 SMA overhead resistance) | Trim 25-33% of position |
| Relief fails and price rolls back below $78 | Convert to Underweight with 55-65% trim magnitude |
| Weekly close > $80.39 (200 SMA) on volume >10M | Add 1/3 position (first increment) |
| Price tests $83 (50 SMA) | Add 1/3 position (second increment) |
| Breakout above $85 | Add final 1/3 position |
| Flush below $77.83 recovers same day with hammer/engulfing on volume >9M and RSI <35 | Add 1/3 position (aggressive capitulation buy) |
| 15-25% into Q3 earnings print (mid-October) | Trim position to neutralize event risk |
| Bull scenario: gross margin >9%, EPS >$2.50 | Upgrade to Overweight |
| Bear scenario: margin <7.5%, guidance cut, forward EPS revisions toward $12-13 | Downgrade to Underweight with 55-65% trim magnitude |
GM's 5.2x forward P/E and 0.28 PEG ratio represent a generational valuation bottom for a $185B revenue company printing $22B in FCF, where the 200 SMA test is a buying signal, not a breakdown, and aggressive buybacks shrinking shares 8.4% annually create compounding EPS tailwinds.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | $81.15 | bearish |
| close_50_sma | $85.36 | bearish |
| close_200_sma | $80.39 | neutral |
| macd | -1.59 | bearish |
| macds | -0.91 | bearish |
| macdh | -0.68 | bearish |
| rsi | 41.10 | neutral |
| boll_ub | $89.52 | neutral |
| boll_lb | $77.83 | neutral |
| vwma | $82.74 | bearish |
| atr | $2.64 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Weekly close > $80.39 (200 SMA) on volume >10M
Then: Add 1/3 position
GM trades at extreme valuation multiples reserved for generational bottoms
↩ rebuts: “Bear's TTM P/E of 34.94x as 'elevated'”
EV: +26% to $100 within 6 months; +51% to $120+ on Q3 earnings beat · concedes: Bear's HOLD recommendation agrees on the same entry zone, suggesting limited near-term downside but fundamentally different reasoning; TTM P/E of 34.94x is elevated due to Q3 2025 $3.3B loss (but forward P/E of 5.2x is what matters)
GM at 5.2x forward P/E is a warning label, not a buying opportunity—the market is correctly pricing skepticism that the analyst consensus earnings recovery is achievable.
· concedes: GM does generate significant FCF ($22B); Share buybacks are returning capital to shareholders; China exit and Cruise restructuring eliminate future losses; Current price at $79.31 is near multi-year support levels
→ vs conservative: Focused on $1.08 cushion below 200 SMA while ignoring $40-$70 of upside; treats 1.05% margin as structural flaw when it's industry norm; anchors to single quarter TTM ignoring forward $15.04 EPS; 'waiting for confirmation' is analysis paralysis - by the time confirmed, stock has already moved
→ vs neutral: Fence-sitting 'mixed signals' is avoidance not analysis; treats Q3 binary catalyst as if both outcomes equally likely when depressed sentiment/positioning favors positive surprise; consensus already baked into depressed price means any in-line or better print triggers significant upside; 'wait and see' means paying up to get back in after the move
Support: 77.83 · 80.39 · 74 | Resistance: 81.15 · 83.68 · 85.36 · 89.52
GM is at a critical technical juncture following a 13.5% selloff from its $91.66 July peak to $79.31. Short-term trend is bearish with price below the 10 EMA ($81.15), intermediate trend bearish with price ~6.5% below the 50 SMA ($85.36), and long-term trend at a critical decision point near the 200 SMA ($80.39). MACD has confirmed a bearish crossover with expanding histogram, VWMA shows volume-supported decline, and RSI at 41.10 suggests further weakness is possible before reaching oversold extremes. Final transaction proposal: HOLD pending either confirmed reversal or breakdown below critical $80.39 support.
Market Cap
$70.79B
Current Price
~$78.27
P/E Ratio (TTM)
34.94x
Forward P/E
5.20x
PEG Ratio
0.28
Price to Book
1.11
EPS (TTM)
$2.24
Forward EPS
$15.04
Book Value/Share
$70.70
52-Week Range
$54.33 – $91.85
50-Day Average
$85.47
200-Day Average
$80.69
Beta
1.321
TTM Revenue
$185.53B
Gross Profit (TTM)
$18.88B
EBITDA (TTM)
$16.46B
Operating Margin
3.20%
Net Profit Margin
1.05%
Return on Equity
3.16%
Return on Assets
2.25%
Total Assets
$282.74B
Total Liabilities
$219.10B
Stockholders' Equity
$62.00B
Total Debt
$127.70B
Net Debt
$107.56B
Cash & Equivalents
$20.13B
Working Capital
$13.17B
Current Ratio
1.136
Debt-to-Equity Ratio
202.3
Net Debt/EBITDA
~6.5x
Operating Cash Flow (TTM)
~$23.2B
Free Cash Flow (TTM)
$21.93B
Dividend Yield
0.91%
Buyback (TTM)
~$6.8B
Share Count Change YoY
-8.4%
Long-term Debt Trend
Down from $97.4B (Q2 2025) to $90.7B (Q2 2026)
Net Debt Trend
Down from $113.4B to $107.6B
Q1 2025 Revenue
$47.12B
Q2 2025 Revenue
$48.59B
Q3 2025 Revenue
$45.29B
Q4 2025 Revenue
$43.62B
Q1 2026 Revenue
$48.03B
Q3 2025 Net Income
-$3.31B
Q4 2025 Net Income
$2.63B
Q1 2026 Net Income
$1.31B
Implied Fair Value (Conservative 8-10x P/E)
$120-$150
Q3 2025 Gross Profit
-$1.12B
Q3 2025 Operating Income
-$3.65B
Accounts Payable
$28.84B
Accrued Expenses
$30.98B
Q1 2026 Buyback
$2.0B
Q2 2026 Buyback
$800M
Q1 2026 Dividends
$608M
52-Week Range Position
63%
Strengths
Concerns
GM presents a classic value vs. value-trap dilemma with extremely attractive forward valuation metrics (Forward P/E 5.2x, PEG 0.28) set against weak profitability (1.05% net margin, 3.16% ROE) and high leverage ($107.56B net debt). The stock expects ~6.7x earnings recovery from $2.24 TTM EPS to $15.04 forward EPS, supported by strong $21.93B TTM free cash flow and aggressive buybacks reducing share count 8.4%. However, a Q3 2025 loss of $3.31B and razor-thin margins raise execution risk. The rating is HOLD with positive lean for long-term value investors given 53-92% implied upside to fair value, while short-term traders should await technical confirmation given bearish moving average positioning.
Macro: The macro environment is mixed but constructive: the Fed is firmly pricing "higher for longer" with 96% probability of zero rate cuts in 2026, recession odds are low at 8%, and Treasury yields are easing following a September jobs miss. However, a geopolitical wildcard exists: the Iran conflict is driving a broad-based inflation impulse (shipping, insurance, commodities) beyond just oil, with only a 3% probability of formal US declaration of war — the market treats it as an ongoing quasi-war. Energy markets show WTI crude in a modal October range of $85–$100, with 62% probability of hitting the $85 low and 44% probability of the $100 high. On trade, escalation dominates: 67% probability Trump raises Canada tariffs by Oct 31 (+25.5pp week), though a US-Canada deal to lower tariffs by Dec 31 remains a 45% probability backstop. GM-specific news was not retrievable; FRED macro series were unavailable due to missing API key.